Metraipolis › archive › dc_f81629aceaad
A Novel Conditional Adversarial Diffusion Model for High-Fidelity OCT-to-OCT Image Translation and Precise Anti-VEGF Therapy Response Prediction in Diabetic Macular Edema — arXiv:2611.03958
- Source
- arXiv (en)
- Original
- https://arxiv.org/abs/2611.03958
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-04T12:57:31.521Z
- SHA-256 of the archived text
587a5a368c0a4c84a75805af1f93285c04a1a453c7273c3ee3b374e36e8c5f7f- Stable URL of this page
https://metraipolis.com/documento/dc_f81629aceaad
How to cite
A Novel Conditional Adversarial Diffusion Model for High-Fidelity OCT-to-OCT Image Translation and Precise Anti-VEGF Therapy Response Prediction in Diabetic Macular Edema — arXiv:2611.03958 — arXiv (en), https://arxiv.org/abs/2611.03958 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_f81629aceaad (Metraipolis archive dc_f81629aceaad, sha256 587a5a368c0a4c84a75805af1f93285c04a1a453c7273c3ee3b374e36e8c5f7f)
BibTeX
@misc{dcf81629aceaad,
title = {A Novel Conditional Adversarial Diffusion Model for High-Fidelity OCT-to-OCT Image Translation and Precise Anti-VEGF Therapy Response Prediction in Diabetic Macular Edema — arXiv:2611.03958},
howpublished = {arXiv (en)},
url = {https://arxiv.org/abs/2611.03958},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_f81629aceaad; sha256 587a5a368c0a4c84a75805af1f93285c04a1a453c7273c3ee3b374e36e8c5f7f},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2611.03958. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Diabetic macular edema (DME) is a leading cause of severe vision loss among working-age adults. Although intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections currently serve as the first-line therapy for DME, a notable subset of patients fails to respond despite the substantial cost and clinical burden, suggesting they may benefit more from alternative interventions. Automated, noninvasive pre-treatment response assessment could therefore spare non-responders from the current trial-and-error treatment paradigm. In this study, we propose a novel conditional adversarial diffusion framework that synthesizes post-treatment optical coherence tomography (OCT) images from baseline scans, enabling the derivation of each patient's initial response to anti-VEGF therapy. The model was developed with subject-level 5-fold cross-validation on a US cohort (n = 127) and externally validated on an independent Iranian cohort (n = 44). Benchmarked against fourteen baseline and state-of-the-art translation models, the proposed model achieved the best treatment-response prediction performance among the methods evaluated for that task on both cohorts, with balanced accuracies of 85.7% and 93.0% on the US cohort and 85.2% and 95.3% on the external Iranian cohort at the 10% and 20% central subfield thickness reduction thresholds, respectively. Ultimately, this framework offers a decision-support tool to help ophthalmologists anticipate initial anti-VEGF outcomes in DME prior to treatment initiation, toward personalized therapy selection. The source code will be made publicly available upon acceptance. Tema degli esploratori: statistica e scienza dei dati (elenco arXiv cs.CV, nuovi lavori del giorno). Categorie arXiv: Image and Video Processing (eess.IV) ; Computer Vision and Pattern Recognition (cs.CV). Pagina del lavoro: https://arxiv.org/abs/2611.03958 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina. Letto il 2026-11-04T12:33:47.242Z dalla pagina https://arxiv.org/list/cs.CV/new (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).